full program

Please click the image to enlarge the program for maxmimum visibility

Poster Abstracts

abs#101 Identifying a novel inflammatory disorder caused by mutation in coatomer complex I - Hongyu HZ Zheng

abs#102 Drug targeting of colorectal cancers including cancer stem cells - Reem ALHulais

abs#103 Novel pre-conditioning regimens prior to adoptive immunotherapy in mice - Joanne E Davis

abs#104 Targeted radiotherapy [177Lu]-PSMA-I&T activates the tumour microenvironment for cellular immunotherapy in patient-derived xenograft models of prostate cancer - Isabel M Everard

abs#105 Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in tumour-free mice: consequences for fertility of female cancer survivors - Jordan N Higgins

abs#106 Immunological Changes in Marginal Zone Lymphoma Patients Undergoing Combination Therapy with Venetoclax and Ibrutinib: Insights from a Longitudinal Study - Hong Han (Lina) Le

abs#107 Uncovering the mechanisms of ovarian damage induced by checkpoint inhibitor immunotherapy - Yasmin M Lewis

abs#108 CD28 stimulation enhances CAR T cell differentiation, particularly in older patients, but CD28 abundance is predictive of CAR T cell product quality. - Palak H Mehta

abs#109 Overcoming immune checkpoint inhibitor resistance to improve melanoma therapy - Davide Moi

abs#110 Expression of specialized proteasome subunits are associated with favorable outcomes of immune checkpoint blockade for non-small cell lung cancer - Vivek Naranbhai (Withdrawn)

abs#111 CRISPR-HDR engineering of T cells for immunotherapy purposes - Maria N. de Menezes

abs#112 Activating the endogenous armoury: anticancer drugs as immunotherapy enablers - Hieu Nguyen

abs#113 Regulation of exhausted CD8+ T cell differentiation by IKZF transcription factors - Sinead M Reading

abs#114 Engineering haematopoietic stem cells for in-situ generation of CAR-NK cells - Kelden Richardson

abs#115 Investigating Peripheral CD8+ T cell Tolerance in Colorectal Cancer – the TIPTOE Trial - Sara Roth

abs#116 Core fucosylation of IL-15 receptor delineates homeostatic proliferation and apoptosis signalling required for natural killer cell development - Harrison Sudholz

abs#117 CD155 PLAYS A DOMINANT ROLE IN MODULATING NK CELL ACTIVATION. - Tania Allin Vargas Pavia

abs#118 High-Affinity T Cell Receptor Discovery for Precision Ovarian Cancer T Cell Receptor Therapy - Anusha Yellapragada

abs#119 Interleukin-2, not chemokine receptors CXCR3, CXCR5 or CXCR6, controls Th1/Tfh fate bifurcation during blood-stage malaria. - Takahiro Asatsuma

abs#120 A deep profiling of the SARS-CoV-2 immunopeptidome with a broad coverage of the viral genome - Asolina Braun

abs#121 Antigen uptake and presentation by human lymphoid organ fibroblasts - Zoe Chua

abs# 122 Evaluating the role of AP-1 transcription factors in CD8+ T cell differentiation and fate - Christian Deo T. Deguit

abs#123 mRNA vaccine against malaria tailored for liver-resident memory T cells - Lauren E Holz

abs#124 Variation in KIR3DL1-allotype binding to HLA ligands modifies the effects of education and detection of HLA loss - Philippa M Saunders